Citation APA
Benboubker, L., Dimopoulos, M. A., Dispenzieri, A., Catalano, J., Belch, A. A., Cavo, M., Pinto, A., Weisel, K. C., Ludwig, H., Bahlis, N. N., Banos, A., Tiab, M., Delforge, M., Cavenagh, J., Geraldes, C., Lee, J.-J., Chen, C., Oriol, A., de la Rubia, J., Qiu, L., White, D. J., Binder, D., Anderson, K. C., Fermand, J.-P., Moreau, P., Attal, M., Knight, R., Chen, G., Van Oostendorp, J., Jacques, C., Ervin-Haynes, A., Avet-Loiseau, H., Hulin, C., Facon, T., Meuleman, N., et al. (2014). Lenalidomide and dexamethasone in transplant-ineligible patients with myeloma. The New England journal of medicine, 371(10), 906-917. doi:10.1056/NEJMoa1402551
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/267165